RA Rudick

A phase III trial of intramuscular recombinant interferon beta as treatment for exacerbating-remitting multiple sclerosis: design and conduct of study and baseline characteristics of patients

L. Jacobs, DL Cookfair, RA Rudick et al. · Multiple Sclerosis Journal · 1995 · 116 citations

Life Sciences, Neurology, Pharmacotherapy +17

Assessing disability progression with the Multiple Sclerosis Functional Composite

RA Rudick, CH Polman, JA Cohen et al. · Multiple Sclerosis Journal · 2009 · 105 citations

Medicine, Neurology, Neuroimmunology +16

Intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis: a 15-year follow-up study

R.A. Bermel, Bianca Weinstock‐Guttman, Dennis Bourdette et al. · Multiple Sclerosis Journal · 2010 · 76 citations

Medicine, Neurology, Pharmacotherapy +14

Revisiting The Multiple Sclerosis Functional Composite: proceedings from the National Multiple Sclerosis Society (NMSS) Task Force on Clinical Disability Measures

Daniel Ontaneda, Nicholas G. LaRocca, Timothy Coetzee et al. · Multiple Sclerosis Journal · 2012 · 75 citations

Nursing, Neurology, Disability Management +10

Multiple sclerosis progression in a natural history study: Predictive value of cerebrospinal fluid free kappa light chains

RA Rudick, SV Medendorp, Marie Namey et al. · Multiple Sclerosis Journal · 1995 · 49 citations

Life Sciences, Immunology, Neurology +17